Page last updated: 2024-10-23

bromhexine and Leiomyosarcoma

bromhexine has been researched along with Leiomyosarcoma in 1 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Leiomyosarcoma: A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flaherty, G1
McCarthy, P1
Mortimer, G1

Other Studies

1 other study available for bromhexine and Leiomyosarcoma

ArticleYear
Pulmonary artery leiomyosarcoma: an unusual cause of shortness of breath.
    Irish journal of medical science, 2011, Volume: 180, Issue:1

    Topics: Bromhexine; Dyspnea; Female; Humans; Immunohistochemistry; Kidney Neoplasms; Leiomyosarcoma; Middle

2011